ELLIPTA Dry Powder Versus Metered-Dose Inhalers in an Optimized Clinical Trial Setting.

Kerwin, Edward M; Preece, Andrew; Brintziki, Dimitra; Collison, Kathryn A; Sharma, Raj

Kerwin, Edward M; Preece, Andrew; Brintziki, Dimitra; Collison, Kathryn A; Sharma, Raj.

Afiliación

Kerwin EM; Clinical Research Institute of Southern Oregon, Medford, Ore. Electronic address: ekerwin@criresearch.com.
Preece A; Respiratory Therapy Area Unit, GlaxoSmithKline plc., Stockley Park West, Uxbridge, Middlesex, United Kingdom.
Brintziki D; Respiratory Clinical Statistics, GlaxoSmithKline plc., Stockley Park West, Uxbridge, Middlesex, United Kingdom.
Collison KA; GlaxoSmithKline plc., Research Triangle Park, Durham, NC.
Sharma R; Respiratory Medical Franchise, GlaxoSmithKline plc., Brentford, Middlesex, United Kingdom.

J Allergy Clin Immunol Pract ; 7(6): 1843-1849, 2019.

Article en En | MEDLINE | ID: mdl-30836228

Asunto(s)

Asma/tratamiento farmacológico; Inhaladores de Polvo Seco; Inhaladores de Dosis Medida; Administración por Inhalación; Adulto; Anciano; Estudios Cruzados; Femenino; Humanos; Masculino; Persona de Mediana Edad

Palabras clave

Clinical trial; Dry powder inhaler; ELLIPTA; Inhaler errors; Inhaler technique; Inhaler training; Metered-dose inhaler; Optimized technique

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Asma / Inhaladores de Dosis Medida / Inhaladores de Polvo Seco Tipo de estudio: Clinical_trials Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Allergy Clin Immunol Pract Año: 2019 Tipo del documento: Article

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google